Application of SWOT, Lotus Flower and SCAMPER frameworks in strategic analysis and innovation planning of a new antifungal cream

Foot mycosis, known as the «Athlete foot» is one of the most common fungal skin lesions, which is a significant health problem, affecting about 3% of the world's population. Historically, the mycosis of the feet is widespread in military conditions due to humidity, unsanitary and prolonged wearing of closed shoes, which contributes to its spread of up to 43% among servicemen. In tropical climates, fungal infections account for up to 75% of skin diseases in this group. Despite the presence of local and oral antifungal agents, increasing prevalence, frequent relapses and medication resistance indicate dissatisfied needs for effective therapy. This creates a commercial incentive for the development of a new antifungal agent. The purpose of the work is to conduct a comprehensive integrated strategic analysis for the development and commercialization of a new antifungal drug for the treatment of foot mycosis, using SWOT analysis, Lotus Flower technique and Scamper Framework, followed by creating effective recommendations for optimizing the path from research to the market. The new tool has a unique mechanism of action, a potentially best safety profile and a formula that provides a competitive advantage in the pharmaceutical market. Pathophysiology of foot mycosis caused by derichophyton Rubrum (Trichophyton Interigitis), emphasizes the need for drugs that counteract immune suppression and reduce relapses. SWOT analysis reveals strengths (new formula, convenience, purposeful action), weaknesses (high costs, risks of resistance), opportunities (market growth, export) and threats (regulatory restrictions, competition of generics). Lotus Flower technique generates ideas for improving patients' commitment, expanding market niches and reducing costs, while Scamper offers specific improvements: replacement of components, combination with other substances, adaptation for different groups, modification of shape or dosage, use for prevention, elimination. Recommendations include capitalization of scientific advantages through careful clinical trials, solving resistance problems, optimization of convenience for patients, use of market opportunities, cost management through partnerships, etc. The integrated approach provides scientific and commercial success, solving dissatisfied medical and pharmaceutical needs.